Literature DB >> 12095721

Percutaneous compression plating (PCCP) versus the dynamic hip screw for pertrochanteric hip fractures: preliminary results.

S E Brandt1, S Lefever, H M J Janzing, P L O Broos, P Pilot, B J J Houben.   

Abstract

The percutaneous compression plate (PCCP) is a new implant for the minimally invasive treatment of pertrochanteric hip fractures that might reduce blood loss, wound problems and prevent devascularization of bone fragments. A quicker operation with minimal blood loss is better in the older patients. We performed a prospective, randomized clinical trial to compare the PCCP with the well-known dynamic hip screw (DHS). A total of 71 patients with an Evans type 1A-D pertrochanteric hip fractures were included. We measured the operation duration, blood loss, wound healing, complications, fracture healing and functional outcome. In total, 33 PCCP and 38 DHS were implanted. The mean operation times were 69.2 and 46.6 min for DHS and PCCP, respectively (P = 0.000). Blood transfusions were given in 24 DHS patients compared with six PCCP patients (P = 0.000). There were 27 haematomas in the DHS group and eight in the PCCP group (P = 0.000). There were no differences in fracture healing and the functional outcome between the two implants (P = 0.767, ns). Although this is a preliminary study with a relatively small number of patients and short follow-up, the PCCP seems similar to the DHS in relation to bone healing and stability, but with significant advantages for blood loss, soft tissue healing and operation time.

Entities:  

Mesh:

Year:  2002        PMID: 12095721     DOI: 10.1016/s0020-1383(02)00080-3

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  9 in total

1.  Minimally invasive dynamic hip screw for fixation of hip fractures.

Authors:  Michael Ho; Giorgio Garau; Gayle Walley; Francesco Oliva; Alfredo Schiavone Panni; Umile Giuseppe Longo; Nicola Maffulli
Journal:  Int Orthop       Date:  2008-05-14       Impact factor: 3.075

Review 2.  Surgical interventions for treating extracapsular hip fractures in older adults: a network meta-analysis.

Authors:  Sharon R Lewis; Richard Macey; Joseph Lewis; Jamie Stokes; James R Gill; Jonathan A Cook; William Gp Eardley; Martyn J Parker; Xavier L Griffin
Journal:  Cochrane Database Syst Rev       Date:  2022-02-10

3.  Outcome of percutaneous compression plate for treatment of femoral neck fractures: mean follow-up of 4.4 years.

Authors:  Zhe-Yu Jin; Chao Gu; Hui-Lin Yang; Ming Xu
Journal:  Int Orthop       Date:  2022-04-23       Impact factor: 3.479

Review 4.  Extramedullary fixation implants and external fixators for extracapsular hip fractures in adults.

Authors:  Martyn J Parker; Avishek Das
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

5.  A new device to treat intra-capsular fracture neck of femur non-union.

Authors:  P Mukherjee; M J Ashworth
Journal:  Strategies Trauma Limb Reconstr       Date:  2010-09-29

6.  Percutaneous compression plating versus gamma nail for the treatment of pertrochanteric hip fractures.

Authors:  Rinaldo Giancola; Guido Antonini; Giacomo Delle Rose; Cornelio Crippa
Journal:  Strategies Trauma Limb Reconstr       Date:  2008-03-29

7.  Clinical and functional outcomes of the PCCP study: a multi-center prospective study in Italy.

Authors:  G Antonini; R Giancola; D Berruti; E Blanchietti; P Pecchia; V Francione; P Greco; T C Russo; L Pietrogrande
Journal:  Strategies Trauma Limb Reconstr       Date:  2013-03-31

8.  Percutaneous compression plate versus dynamic hip screw for treatment of intertrochanteric Hip fractures: a meta-analyse of five randomized controlled trials.

Authors:  Lei Zhang; Jie Shen; Shengpeng Yu; Qiang Huang; Zhao Xie
Journal:  ScientificWorldJournal       Date:  2014-03-10

Review 9.  Optimal surgical methods to treat intertrochanteric fracture: a Bayesian network meta-analysis based on 36 randomized controlled trials.

Authors:  Yan-Xiao Cheng; Xia Sheng
Journal:  J Orthop Surg Res       Date:  2020-09-10       Impact factor: 2.359

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.